Reta stalled...now what?

Hong Kong Yanpep International
The clen comparison at a stall is a common crossroads - people who've run stimulants before tend to look for something to add rather than adjusting what's already there. The albuterol preference over clen is pharmacologically defensible: beta-2 selectivity and shorter half-life reduce cardiac risk. Modafinil's controlled status makes sourcing friction a real variable. What's worth examining first at a Reta stall is whether the dose ladder has room - 4 months is often early for the ceiling, and the stall pattern at that mark frequently responds to a dose bump before any add-ons are needed. The glucagon comparison gets interesting because both affect hepatic glucose output, but the mechanisms differ enough that stacking logic requires knowing what the stall is from: metabolic adaptation, dose tolerance, or composition shift.
 
Switching from split to weekly on the same dose is a real lever for stalls - the consolidated pulse affects the mechanism differently.
 
Sixty-day stalls on Reta are common after a fast early drop - the 25 lbs already happened, and the body adjusts to a new set point. Dose increase to 2mg is the standard next step, but strength training during that window changes body composition even when the scale stays flat.
 
The 5% to 30% variation in trial outcomes is crucial framing for understanding plateaus - the average result is the average, not a guarantee for every individual. If Reta has given its initial benefit and plateaued, the case for trying something else or adding a layer is reasonable.
 
The muscle-mass-offsetting-fat-loss thing is real with heavy lifting - a scale that isn't moving while you're training hard isn't necessarily a stall. The reta carb sensitivity is also worth checking; some people genuinely need a certain carbohydrate floor to see the full glucagon effect.
 
Back
Top